Coronavirus: Mauritius to use hydroxychloroquine as a virus treatment only on patient’s written consent
Port Louis, Mauritius (PANA) - Henceforth, hospitalised patients with COVID-19 will be informed as regards the risks and secondary effects of hydroxychloroquine and will be administered the medication only with their written consent